CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Lower urinary tract symptoms in men, age-related (including symptoms of benign prostatic hyperplasia/hypertrophy) - Management
Basis for recommendation
These recommendations are in line with the guideline The management of lower urinary tract symptoms in men from the National Institute for Health and Clinical Excellence (NICE) [NICE, 2010] and are based on expert opinion [Reynard et al, 2006; NICE, 2010].
- The IPSS includes the American Urological Association severity of symptoms score, which was developed and validated by the multidisciplinary measurement committee of the American Urological Association [Barry et al, 1992].
- The NICE systematic review found no study that assessed whether scoring symptoms affect clinical outcome.
- The NICE guideline development group highlighted the fact that completing the symptom score would be difficult or impossible for people who are blind, cannot read English, or have learning disabilities.
© NHS Institute for Innovation and Improvement